# clm_EEEAB419DCCD

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 16,896,100,000 United States dollar  
valid_from: 2013-09-30  
valid_to: 2013-12-31  
published: 2013-10-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_449F1D02A97D  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 16,896,100,000 United States dollar", as of 2013-09-30 (until 2013-12-31). Claim clm_EEEAB419DCCD, https://asof.is/claim/clm_EEEAB419DCCD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947813000057/0000059478-13-000057-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2013, filed 2013-10-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947813000057/0000059478-13-000057-index.htm (primary, SEC EDGAR 10-Q Q3 FY2013, published 2013-10-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 15,236,400,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_EEEAB419DCCD](/claim/clm_EEEAB419DCCD.md) | [clm_1701758C9C6B](/claim/clm_1701758C9C6B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.